Susan Galbraith

Susan Galbraith

Corporate Officer/Principal at ASTRAZENECA PLC
Consumer Services
Health Technology
Finance

Profile

Susan Mary Galbraith is currently Executive VP-Oncology Research & Development at AstraZeneca PLC since 2021, with employment at AstraZeneca PLC starting in 2010.
Former roles include Director at the American Association for Cancer Research from 2021 to 2024, Member-Supervisory Board at BB Biotech AG from 2020 to 2021, Independent Non-Executive Director at Horizon Discovery Group Ltd. from 2014 to 2020, and Vice President-Oncology & Clinical Biomarkers at Bristol-Myers Squibb Pharmaceuticals Ltd. in 2010.
Education includes undergraduate studies at The University of Manchester, graduate studies at the University of Cambridge, and a doctorate from the University of London.

Susan Galbraith active positions

CompaniesPositionStart
ASTRAZENECA PLC Corporate Officer/Principal 01/01/2010

Former positions of Susan Galbraith

CompaniesPositionEnd
Director/Board Member 01/01/2024
BB BIOTECH AG Director/Board Member 02/07/2021
HORIZON DISCOVERY GROUP PLC Director/Board Member 30/04/2020
Corporate Officer/Principal 01/01/2010
See the detail of Susan Galbraith's experience

Training of Susan Galbraith

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

61

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies8

Finance

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Commercial Services

Distribution Services

  1. Stock Market
  2. Insiders
  3. Susan Galbraith